Up next

Autoplay

Chronic Myeloid Leukemia Treatment Discontinuation

2 Views • 06/27/23
Share
Embed
administrator
administrator
Subscribers
0

The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay